The ADRs derived from clinical studies and post-marketing surveillance with Amoxicillin/clavulanic acid, sorted by MedDRA System Organ Class are listed in Table 5.
The following terminologies have been used in order to classify the occurrence of undesirable effects.
Very common (≥1/10);
Common (≥1/100 to <1/10);
Uncommon (≥1/1,000 to <1/100);
Rare (≥1/10,000 to <1/1,000);
Very rare (<1/10,000)
Not known (cannot be estimated from the available data).
See Table 5.

View ADR Reporting Link